✦ LIBER ✦

Gene therapy in lysosomal diseases

✍ Scribed by C Caillaud; L Poenaru

Book ID: 117575088
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 53 KB
Volume: 54
Category: Article
ISSN: 0753-3322
DOI: 10.1016/s0753-3322(00)00009-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Widespread gene transduction to the cent

Widespread gene transduction to the central nervous system by adenovirus in utero: implication for prenatal gene therapy to brain involvement of lysosomal storage disease

✍ Jin-Song Shen; Xing-Li Meng; Hiroshi Maeda; Toya Ohashi; Yoshikatsu Eto 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 492 KB

## Abstract ## Background In some lysosomal storage diseases, considerable alterations of the central nervous system (CNS) occur prior to birth and neurodegeneration progresses rapidly soon after birth causing early death in patients. No effective treatment is available after birth. Treatment may

Gene therapy/cell therapy for lysosomal

Gene therapy/cell therapy for lysosomal storage disease

✍ Y. Eto; T. Ohashi 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 64 KB

Gene therapy for lysosomal storage disea

Gene therapy for lysosomal storage disease: A no-brainer?

✍ Sly, William S.; Vogler, Carole 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 271 KB

Liposomes in the therapy of lysosomal st

Liposomes in the therapy of lysosomal storage diseases

✍ Gregoriadis, Gregory 📂 Article 📅 1978 🏛 Nature Publishing Group 🌐 English ⚖ 261 KB

Substrate reduction therapy for lysosoma

Substrate reduction therapy for lysosomal storage diseases

✍ T M Cox 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 404 KB

Gene therapy for lysosomal storage disea

Gene therapy for lysosomal storage diseases: the lessons and promise of animal models

✍ N. Matthew Ellinwood; Charles H. Vite; Mark E. Haskins 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 596 KB

## Abstract There are more than 40 different forms of inherited lysosomal storage diseases (LSDs) known to occur in humans and the aggregate incidence has been estimated to approach 1 in 7000 live births. Most LSDs are associated with high morbidity and mortality and represent a significant burden